Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-05-15 @ 4:13 PM
Study NCT ID:
NCT01194960
Status:
TERMINATED
Last Update Posted:
2020-10-19
First Post:
2010-09-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Sponsor:
Oxford BioMedica
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TV2/001/09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |